Progress in antisense therapeutics.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Hematologic pathology

• Publication date

  1996-10-08

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/CHIN.199641295PMID 7559256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progress in antisense therapeutics

  1996cited by this paper

• Emerging Role and Therapeutic Potential of lncRNAs in Colorectal Cancer

  2020cites this paper
• Signal Transduction Inhibition

  2020cites this paper
• Oligonucleotide therapies for RNA and DNA : modulation of natural splice-variants, DNA structure & characterization of new synthetic nucleotides and reporter cell lines

  2016cites this paper
• Mechanism of Alternative Complement Pathway Dysregulation by a Phosphorothioate Oligonucleotide in Monkey and Human Serum

  2014cites this paper
• Cap‐Dependent Translation Initiation Factor eIF4E: An Emerging Anticancer Drug Target

  2012cites this paper
• Pharmacokinetics and Toxicity in Rats and Monkeys of coDbait: A Therapeutic Double-stranded DNA Oligonucleotide Conjugated to Cholesterol

  2012cites this paper
• Therapeutic Potential of Oligonucleotide-Based Therapy in Cardiovascular Disease

  2012cites this paper
• Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy.

  2012cites this paper
• Antisense therapy, a magic bullet for the treatment of various diseases: Present and future prospects

  2011cites this paper
• Liposome-mediated therapy of neuroblastoma.

  2009cites this paper
• Profiling of dynamically changed gene expression in dorsal root ganglia post peripheral nerve injury and a critical role of injury‐induced glial fibrillary acetic protein in maintenance of pain behaviors

  2009cites this paper
• NFκB Decoy Oligodeoxynucleotide-Based Therapy in Cardiovascular Diseases

  2008cites this paper
• Delivery of Small Interfering RNA. A Review and an Example of Application to a Junction Oncogene

  2008cites this paper
• Increase in nuclease resistance and incorporation of NF‐κB decoy oligodeoxynucleotides by modification of the 3′‐terminus

  2007cites this paper
• Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3'-terminus.

  2007cites this paper
• Imaging Gene Expression: Concepts and Future Outlook

  2006cites this paper
• Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide.

  2006cites this paper
• Prodrug approaches of nucleotides and oligonucleotides.

  2006cites this paper
• Gene Therapy vs Pharmacotherapy

  2005cites this paper
• Murine double minute 2 as a therapeutic target for radiation sensitization of lung cancer

  2005cites this paper
• Transcription Factors

  2004cites this paper
• Quantitative Assay Development for PET

  2004cites this paper
• The Use of Gene Therapy in Cancer Research and Treatment

  2004cites this paper
• Potential of Transcription Factor Decoy Oligonucleotides as Therapeutic Approach

  2004cites this paper
• Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides.

  2004cites this paper
• Oligonucleotide-based molecular therapy for restenosis after angioplasty.

  2003cites this paper
• Novel Anticancer Agents in Clinical Development

  2003cites this paper
• Strategy of antisense oligonucleotides – actual state of art in advanced clinical studies on therapy of selected neoplastic diseases

  2003cites this paper
• The role of parallel signaling pathways in maintaining lymphoid cell survival

  2002cites this paper
• Recent progress in gene therapy for cardiovascular disease.

  2002cites this paper
• Assessment of the genotoxic potential of ISIS 2302: a phosphorothioate oligodeoxynucleotide.

  2002cites this paper
• Gene therapy in vascular medicine: recent advances and future perspectives.

  2001cites this paper
• The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides

  2001cites this paper
• Freeze Drying Properties of Some Oligonucleotides

  2001cites this paper
• This information is current as Macrophages , and Pulmonary Inflammation Expression , Mediator Release from Aerosolized Syk Antisense Suppresses Syk

  2000cites this paper
• Determination of free and encapsulated oligonucleotides in liposome formulated drug product.

  2000cites this paper
• Use of Polyethylenimine-Adenovirus Complexes to Examine Triplex Formation in Intact Cells

  2000cites this paper
• Oligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs?

  2000cites this paper
• Antisense Oligonucleotides in the Study of Central Mechanisms of the Cardiovascular Regulation

  2000influential citation
• Aerosolized Syk Antisense Suppresses Syk Expression, Mediator Release from Macrophages, and Pulmonary Inflammation1

  2000cites this paper
• PET: the merging of biology and imaging into molecular imaging.

  2000cites this paper
• Antisense--time to shoot the messenger.

  1999cites this paper
• Molecular mechanisms of action of antisense drugs.

  1999cites this paper
• Analysis of internal (n-1)mer deletion sequences in synthetic oligodeoxyribonucleotides by hybridization to an immobilized probe array.

  1999cites this paper
• Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer.

  1999cites this paper
• Imaging gene expression: Principles and assays

  1999cites this paper
• Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation

  1999cites this paper
• Use of Antisense Vectors and Oligodeoxynucleotides in Neuro-Oncology

  1998cites this paper
• Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice.

  1998cites this paper
• Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.

  1998cites this paper
• Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.

  1998cites this paper
• This information is current as Hepatitis B Surface Antigen Immunity in Mice Immunized with Recombinant CpG DNA Is a Potent Enhancer of Specific

  1998cites this paper
• Oligonucleotide-Based Gene Therapy for Cardiovascular Disease

  1998cites this paper
• Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.

  1997cites this paper
• Synthetic oligonucleotides: Useful molecules? A review.

  1997cites this paper
• Modified mRNA Rescue of Maternal CK1/8 mRNA Depletion in Xenopus Oocytes

  1997cites this paper
• Resonance Raman analysis of a fluorescently labeled oligonucleotide forming a very stable hairpin

  1997cites this paper
• Expression of a D2 dopamine receptor antisense RNA in brain inhibits D2-mediated behaviors.

  1997cites this paper
• Anti-inflammatory therapies: application of molecular biology techniques in intensive care medicine

  1997cites this paper
• Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides.

  1997cites this paper
• Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.

  1997cites this paper
• Antisense strategies in neurobiology.

  1997cites this paper
• Determination of Sodium Acetate in Antisense Oligonucleotides by Capillary Zone Electrophoresis

  1997cites this paper
• Evaluation of the Toxicity of ISIS 2302, a Phosphorothioate Oligonucleotide, in a 4-Week Study in CD-1 Mice

  1997cites this paper
• Strategy for designing specific antisense oligonucleotide sequences

  1997cites this paper
• Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.

  1997cites this paper
• Combining the preparation of oligonucleotide arrays and synthesis of high-quality primers.

  1996cites this paper
• Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes

  1996cites this paper